Richard Anthony Cunningham
CEO & DirectorMr. Richard Anthony Cunningham, also known as Richie, is Chief Executive Officer and Director of Anebulo Pharmaceuticals, Inc. since October 2023. He served as Chief Executive Officer and Director at Tyme Technologies, Inc. since November 23, 2020 until September 16, 2022. He had been the Chief Executive Officer and President of IXC Discovery, Inc. (formerly, Icagen Inc.) since November 24, 2014. He had also served as a Director there since April 2020. He was President, Chief Executive Officer, Director of Icagen-T, Inc. He has leadership past work in the healthcare industry in various leadership roles including Marketing, Sales, Strategy and ContrActing, as well as leading various Business Development projects. His past work includes the commercialization and launch of multiple products in the Infectious Disease, Dermatology, Oncology, Cardiovascular, Respiratory and Diabetes therapeutic areas. Most recently, he led a team at Boehringer-Ingelheim strategically focused on Sales Acceleration, Product Launch Effectiveness and Operational Excellence. Prior to Boehringer-Ingelheim, he was at Valeant Pharmaceuticals where he was a senior executive in the commercial organization leading sales, marketing and contrActing activities. He began his career in healthcare at Premier Inc., a healthcare company that served as a group purchasing and service organization for hospitals throughout the nation. While at Premier he served as the Marketing Director at Premier Practice Management, a subsidiary and start-up company of Premier Inc. In addition to establishing his healthcare career and in parallel, he also excelled as a professional athlete in the NFL holding All-Pro honors as a placekicker for the Dallas Cowboys, then later the Carolina Panthers and Jacksonville Jaguars. His career in the NFL spanned from 1994 until his retirement in 2002.
Positions
- Company NameAnebulo Pharmaceuticals, Inc.Stock CodeANEBPositionCEO & Director
